{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:58:14Z","timestamp":1790755094756,"version":"4.1.0"},"reference-count":85,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1097\/cco.0000000000000042","type":"journal-article","created":{"date-parts":[[2013,11,27]],"date-time":"2013-11-27T09:14:55Z","timestamp":1385543695000},"page":"100-107","source":"Crossref","is-referenced-by-count":88,"title":["Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer"],"prefix":"10.1097","volume":"26","author":[{"given":"Abigale","family":"Lade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke A.","family":"Noon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210128","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ajg.2012.128","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.","volume":"107","author":"Chalasani","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R2-16-20210128","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in adults.","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"R3-16-20210128","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1749-6632.2012.06737.x","article-title":"Obesity, metabolic dysregulation, and cancer: a growing concern and an inflammatory (and microenvironmental) issue.","volume":"1271","author":"Hursting","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"R4-16-20210128","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1161\/ATVBAHA.111.241927","article-title":"Growth signals, inflammation, and vascular perturbations: mechanistic links between obesity, metabolic syndrome, and cancer.","volume":"32","author":"Hursting","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R5-16-20210128","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1478-3231.2008.01718.x","article-title":"Prevalence and associated factors of nonalcoholic fatty liver disease in patients with type-2 diabetes mellitus.","volume":"29","author":"Leite","year":"2009","journal-title":"Liver Int"},{"key":"R6-16-20210128","first-page":"205","article-title":"Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.","volume":"57","author":"Prashanth","year":"2009","journal-title":"J Assoc Physicians India"},{"key":"R7-16-20210128","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/hep.22575","article-title":"Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial.","volume":"49","author":"Harrison","year":"2009","journal-title":"Hepatology"},{"key":"R8-16-20210128","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis.","volume":"51","author":"Promrat","year":"2010","journal-title":"Hepatology"},{"key":"R9-16-20210128","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cct.2008.09.003","article-title":"Pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis: PIVENS trial design.","volume":"30","author":"Chalasani","year":"2009","journal-title":"Contemp Clin Trials"},{"key":"R10-16-20210128","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.lfs.2012.11.004","article-title":"Nonalcoholic fatty liver disease: current and potential therapies.","volume":"92","author":"Ibrahim","year":"2013","journal-title":"Life Sci"},{"key":"R11-16-20210128","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.23623","article-title":"A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease.","volume":"52","author":"Musso","year":"2010","journal-title":"Hepatology"},{"key":"R12-16-20210128","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/ajg.2013.168","article-title":"Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children.","volume":"108","author":"Feldstein","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"R13-16-20210128","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/MPG.0b013e3181e376be","article-title":"Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD.","volume":"51","author":"Fitzpatrick","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R14-16-20210128","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/MCG.0b013e3181bdefe2","article-title":"Serum fragmented cytokeratin 18 levels reflect the histologic activity score of nonalcoholic fatty liver disease more accurately than serum alanine aminotransferase levels.","volume":"44","author":"Tsutsui","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"R15-16-20210128","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1440-1746.2008.05731.x","article-title":"The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease.","volume":"24","author":"Malik","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"R16-16-20210128","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"R17-16-20210128","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","article-title":"Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.","volume":"10","author":"White","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R18-16-20210128","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.24491","article-title":"The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.","volume":"54","author":"Bhala","year":"2011","journal-title":"Hepatology"},{"key":"R19-16-20210128","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.23527","article-title":"The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.","volume":"51","author":"Ascha","year":"2010","journal-title":"Hepatology"},{"key":"R20-16-20210128","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/MEG.0b013e328357cdd7","article-title":"Peripheral intrahepatic cholangiocarcinoma occurring in patients without cirrhosis or chronic bile duct diseases: epidemiology and histopathology of distant nontumoral liver in 57 White patients.","volume":"25","author":"Nkontchou","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R21-16-20210128","first-page":"1761","article-title":"Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis Arch Pathol Lab M","volume":"132","author":"Guzman","year":"2008","journal-title":"ed"},{"key":"R22-16-20210128","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/ijc.25797","article-title":"Nonalcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis.","volume":"128","author":"Ertle","year":"2011","journal-title":"Int J Cancer"},{"key":"R23-16-20210128","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer.","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"R24-16-20210128","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1053\/j.gastro.2012.09.008","article-title":"Sterile inflammation in the liver.","volume":"143","author":"Kubes","year":"2012","journal-title":"Gastroenterology"},{"key":"R25-16-20210128","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1172\/JCI57132","article-title":"Inflammatory links between obesity and metabolic disease.","volume":"121","author":"Lumeng","year":"2011","journal-title":"J Clin Invest"},{"key":"R26-16-20210128","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1055\/s-0028-1091981","article-title":"Mechanisms of disease progression in nonalcoholic fatty liver disease.","volume":"28","author":"Jou","year":"2008","journal-title":"Semin Liver Dis"},{"key":"R27-16-20210128","first-page":"9","article-title":"Non alcoholic fatty liver disease and metabolic syndrome.","volume":"13","author":"Paschos","year":"2009","journal-title":"Hippokratia"},{"key":"R28-16-20210128","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/gut.2008.156307","article-title":"Toll-like receptors as targets in chronic liver diseases.","volume":"58","author":"Mencin","year":"2009","journal-title":"Gut"},{"key":"R29-16-20210128","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/gut.2009.199661","article-title":"Nonalcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications.","volume":"59","author":"Stickel","year":"2010","journal-title":"Gut"},{"key":"R30-16-20210128","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature11550","article-title":"Diversity, stability and resilience of the human gut microbiota.","volume":"489","author":"Lozupone","year":"2012","journal-title":"Nature"},{"key":"R31-16-20210128","doi-asserted-by":"crossref","first-page":"12511","DOI":"10.1073\/pnas.0601056103","article-title":"Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice.","volume":"103","author":"Dumas","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R32-16-20210128","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/1469-0691.12140","article-title":"Gut microbiota and nonalcoholic fatty liver disease: new insights.","volume":"19","author":"Aron-Wisnewsky","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"R33-16-20210128","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.numecd.2012.02.007","article-title":"Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease.","volume":"22","author":"Compare","year":"2012","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R34-16-20210128","doi-asserted-by":"crossref","first-page":"G518","DOI":"10.1152\/ajpgi.00024.2006","article-title":"Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis.","volume":"292","author":"Brun","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R35-16-20210128","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.1179721","article-title":"Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5.","volume":"328","author":"Vijay-Kumar","year":"2010","journal-title":"Science"},{"key":"R36-16-20210128","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"key":"R38-16-20210128","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4.","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell"},{"key":"R39-16-20210128","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome.","volume":"499","author":"Yoshimoto","year":"2013","journal-title":"Nature"},{"key":"R40-16-20210128","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40139-012-0003-6","article-title":"Bile acid receptors and liver cancer.","volume":"1","author":"Wang","year":"2013","journal-title":"Curr Pathobiol Rep"},{"key":"R41-16-20210128","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/apt.12084","article-title":"Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and nonalcoholic fatty liver disease.","volume":"36","author":"Zarrinpar","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"R42-16-20210128","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1210\/me.2011-1157","article-title":"Loss of FXR protects against diet-induced obesity and accelerates liver carcinogenesis in obob mice.","volume":"26","author":"Zhang","year":"2012","journal-title":"Mol Endocrinol"},{"key":"R43-16-20210128","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1124\/jpet.111.179390","article-title":"Increased activation of the Wntbeta-catenin pathway in spontaneous hepatocellular carcinoma observed in farnesoid X receptor knockout mice.","volume":"338","author":"Wolfe","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"R44-16-20210128","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1158\/0008-5472.CAN-06-1078","article-title":"Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor.","volume":"67","author":"Yang","year":"2007","journal-title":"Cancer Res"},{"key":"R46-16-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FPC.0b013e328333a1dd","article-title":"The nuclear receptor PXR gene variants are associated with liver injury in nonalcoholic fatty liver disease.","volume":"20","author":"Sookoian","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"R47-16-20210128","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1021\/mp700103m","article-title":"Xenoreceptors CAR and PXR activation and consequences on lipid metabolism, glucose homeostasis, and inflammatory response.","volume":"5","author":"Moreau","year":"2008","journal-title":"Mol Pharm"},{"key":"R48-16-20210128","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/carcin\/bgq277","article-title":"Constitutive activeandrostane receptor promotes hepatocarcinogenesis in a mouse model of nonalcoholic steatohepatitis.","volume":"32","author":"Takizawa","year":"2011","journal-title":"Carcinogenesis"},{"key":"R49-16-20210128","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/10799893.2013.802805","article-title":"The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders.","volume":"33","author":"Stepanov","year":"2013","journal-title":"J Recept Signal Transduct Res"},{"key":"R50-16-20210128","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hep.26019","article-title":"Deficiency of G-protein-coupled bile acid receptor Gpbar1 (TGR5) enhances chemically induced liver carcinogenesis.","volume":"57","author":"Chen","year":"2013","journal-title":"Hepatology"},{"key":"R51-16-20210128","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1126\/science.1070477","article-title":"Vitamin D receptor as an intestinal bile acid sensor.","volume":"296","author":"Makishima","year":"2002","journal-title":"Science"},{"key":"R53-16-20210128","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1440-1746.2011.06892.x","article-title":"Hepatocellular carcinoma and vitamin D: a review.","volume":"26","author":"Chiang","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"R54-16-20210128","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/ejcn.2011.118","article-title":"Vitamin D and type 2 diabetes: a systematic review.","volume":"65","author":"Mitri","year":"2011","journal-title":"Eur J Clin Nutr"},{"key":"R55-16-20210128","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0960-0760(03)00032-3","article-title":"Identification of a Vitamin D response element in the human insulin receptor gene promoter.","volume":"84","author":"Maestro","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R56-16-20210128","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/cbf.951","article-title":"Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D.","volume":"20","author":"Maestro","year":"2002","journal-title":"Cell Biochem Funct"},{"key":"R57-16-20210128","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/hep.24737","article-title":"Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation.","volume":"55","author":"Roth","year":"2012","journal-title":"Hepatology"},{"key":"R58-16-20210128","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cell.2013.03.028","article-title":"A vitamin D receptorSMAD genomic circuit gates hepatic fibrotic response.","volume":"153","author":"Ding","year":"2013","journal-title":"Cell"},{"key":"R59-16-20210128","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1053\/jhep.2003.50097","article-title":"Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype.","volume":"37","author":"Schnabl","year":"2003","journal-title":"Hepatology"},{"key":"R60-16-20210128","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cell.2013.03.020","article-title":"Noncell-autonomous tumor suppression by p53.","volume":"153","author":"Lujambio","year":"2013","journal-title":"Cell"},{"key":"R61-16-20210128","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/hep.25559","article-title":"Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease.","volume":"55","author":"Guy","year":"2012","journal-title":"Hepatology"},{"key":"R63-16-20210128","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/hep.26230","article-title":"Hedgehog pathway and pediatric nonalcoholic fatty liver disease.","volume":"57","author":"Swiderska-Syn","year":"2013","journal-title":"Hepatology"},{"key":"R64-16-20210128","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1053\/j.gastro.2009.06.051","article-title":"Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease.","volume":"137","author":"Syn","year":"2009","journal-title":"Gastroenterology"},{"key":"R65-16-20210128","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrgastro.2012.256","article-title":"Liver fibrosis in 2012: Convergent pathways that cause hepatic fibrosis in NASH.","volume":"10","author":"Friedman","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R66-16-20210128","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nm.2667","article-title":"Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease.","volume":"18","author":"Boulter","year":"2012","journal-title":"Nat Med"},{"key":"R67-16-20210128","first-page":"486","article-title":"Beta-catenin signaling in hepatic development and progenitors: which way does the WNT blow Dev D","volume":"240","author":"Lade","year":"2011","journal-title":"yn"},{"key":"R68-16-20210128","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.biocel.2009.09.001","article-title":"Role of Wntbeta-catenin signaling in liver metabolism and cancer.","volume":"43","author":"Monga","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"R69-16-20210128","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1126\/science.1238525","article-title":"Cell biology. Insulin finds its niche.","volume":"340","author":"Cheetham","year":"2013","journal-title":"Science"},{"key":"R70-16-20210128","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.cell.2013.06.030","article-title":"Transformed Drosophila cells evade diet-mediated insulin resistance through wingless signaling.","volume":"154","author":"Hirabayashi","year":"2013","journal-title":"Cell"},{"key":"R71-16-20210128","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1073\/pnas.0807390106","article-title":"Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog.","volume":"106","author":"Machida","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R72-16-20210128","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1172\/JCI65859","article-title":"Reciprocal regulation by TLR4 and TGF-beta in tumor-initiating stem-like cells.","volume":"123","author":"Chen","year":"2013","journal-title":"J Clin Invest"},{"key":"R73-16-20210128","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1152\/physrev.00030.2009","article-title":"Regulation of mammalian autophagy in physiology and pathophysiology.","volume":"90","author":"Ravikumar","year":"2010","journal-title":"Physiol Rev"},{"key":"R74-16-20210128","doi-asserted-by":"crossref","first-page":"282041","DOI":"10.1155\/2012\/282041","article-title":"Lipophagy: connecting autophagy and lipid metabolism.","volume":"2012","author":"Singh","year":"2012","journal-title":"Int J Cell Biol"},{"key":"R75-16-20210128","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cmet.2010.04.005","article-title":"Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance.","volume":"11","author":"Yang","year":"2010","journal-title":"Cell Metab"},{"key":"R76-16-20210128","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature09782","article-title":"Autophagy in immunity and inflammation.","volume":"469","author":"Levine","year":"2011","journal-title":"Nature"},{"key":"R77-16-20210128","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1053\/j.gastro.2011.12.044","article-title":"Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues.","volume":"142","author":"Hernandez-Gea","year":"2012","journal-title":"Gastroenterology"},{"key":"R78-16-20210128","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1586\/egh.11.4","article-title":"Autophagy in nonalcoholic steatohepatitis.","volume":"5","author":"Amir","year":"2011","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R79-16-20210128","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nature07976","article-title":"Autophagy regulates lipid metabolism.","volume":"458","author":"Singh","year":"2009","journal-title":"Nature"},{"key":"R80-16-20210128","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1101\/gad.2016211","article-title":"Autophagy-deficient mice develop multiple liver tumors.","volume":"25","author":"Takamura","year":"2011","journal-title":"Genes Dev"},{"key":"R81-16-20210128","doi-asserted-by":"crossref","first-page":"9167","DOI":"10.1158\/0008-5472.CAN-08-1573","article-title":"Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma.","volume":"68","author":"Ding","year":"2008","journal-title":"Cancer Res"},{"key":"R82-16-20210128","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/carcin\/bgt063","article-title":"Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition.","volume":"34","author":"Li","year":"2013","journal-title":"Carcinogenesis"},{"key":"R84-16-20210128","doi-asserted-by":"crossref","first-page":"849","DOI":"10.4161\/auto.19947","article-title":"Autophagy fuels tissue fibrogenesis.","volume":"8","author":"Hernandez-Gea","year":"2012","journal-title":"Autophagy"},{"key":"R85-16-20210128","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis.","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"R86-16-20210128","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jnutbio.2010.10.002","article-title":"Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms.","volume":"22","author":"Iacono","year":"2011","journal-title":"J Nutr Biochem"},{"key":"R87-16-20210128","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhep.2012.08.019","article-title":"Targeting gut flora to prevent progression of hepatocellular carcinoma.","volume":"58","author":"Darnaud","year":"2013","journal-title":"J Hepatol"},{"key":"R88-16-20210128","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1194\/jlr.R008896","article-title":"Genetic determinants of hepatic steatosis in man.","volume":"52","author":"Hooper","year":"2011","journal-title":"J Lipid Res"},{"key":"R89-16-20210128","first-page":"1262","article-title":"The expression patterns and clinical significance of microRNAs in liver diseases and hepatocellular carcinoma.","volume":"19","author":"Guo","year":"2013","journal-title":"Curr Pharm Des"},{"key":"R90-16-20210128","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications.","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"}],"container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCO.0000000000000042","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T19:34:54Z","timestamp":1647545694000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001622-201401000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/cco.0000000000000042","relation":{},"ISSN":["1040-8746"],"issn-type":[{"value":"1040-8746","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}